TS
Tru Singular Health, Inc.
SEC filingBiotechnology · Natick, MA
Amount raised$1Msold at filing
Total offering$1M
Investors in the raise12count reported to the SEC
FiledOct 30, 2026first sale Sep 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Steven GullansExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.